ViruBots™ are engineered viruses. These extremely small “bots” target cancer cells in unique ways. They also stimulate the immune system to act against cancer cells. Timothy P. Cripe, MD, PhD, of Nationwide Children’s Hospital and The Ohio State University has provided a suite of immunotherapy technologies to Open Therapeutics for global crowd-sourcing. This suite of ViruBots have peer review published in vivo results. Assisted by Drs. Su, Guo, Samy, Krishnamoorthy, Dr. Cripe is developing these ViruBots to target fourteen different cancer types as well as neoplasm.
Want to save these project details? Download this brief Project Manifest for your convenience!